Enlarged cerebral ventricles are found in 80% of individuals with schizophrenia, yet the mechanisms that lead to ventricular enlargement are mostly unknown. Scientists have found that two microRNAs play a critical role in a mechanism that results in ventricular enlargement in a type of mouse model. The results were reported in Nature Communications.
Deletion of a region on chromosome 22 (22q11.2-deletion syndrome) increases the risk of developing schizophrenia approximately 30-fold in humans. 22q11-deletion syndrome can be replicated in mice, creating a research model with scientific significance for studying schizophrenia. Researchers have previously observed ventricular enlargement in individuals with 22q11-deletion syndrome and in mouse models.
The researchers wanted to find out what drives ventricular enlargement in models of 22q11-deletion syndrome. They were interested in the motile cilia, structures that line the ventricle walls and help cerebral spinal fluid circulate.
"Schizophrenia itself is polygenic; there is no single gene that can explain all of the symptoms of this complex disease," said senior author. "But the 22q11-deletion syndrome model gives us an opportunity to identify the gene that contributes to ventricular enlargement."
The gene Dgcr8 is found within the region of DNA that is missing in 22q11-deletion syndrome. This gene plays a role in synthesizing microRNAs. The team found that deletion of Dgcr8 reduces the microRNAs miR-382-3p and miR-674-3p. When those microRNAs are reduced, a receptor on the surface of motile cilia lining the ventricle walls called Drd1 is increased.
Results show that when this mechanism is active, two changes occur in the ventricles: The motile cilia move more slowly, and the brain ventricles are enlarged.
"We found that this mechanism is necessary and sufficient for these two things, reduced motile cilia movement and ventricular enlargement," the senior author said. "In our model, we were able to remove the microRNAs and get this effect, and we were able to reintroduce these microRNAs and see that the ventricles and cilia return to normal."
https://www.stjude.org/media-resources/news-releases/2020-medicine-science-news/unraveling-mechanisms-of-ventricular-enlargement-linked-to-schizophrenia.html
https://www.nature.com/articles/s41467-020-14628-y
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fschizophrenia-related&filter=22
MicroRNA's role in ventricular enlargement in schizophrenia
- 1,950 views
- Added
Edited
Latest News
A new gene-editing tool!
DNA methylation changes in shift workers with sleep disorder!
Chromosomally unstable tumor cells specifically require KIF18A for proliferation
Brain opioid receptor alteration with seasonal variation in daylight
Mechanism of membrane-tethered mitochondrial protein synthesis
Other Top Stories
Similar regions of the brain are involved in both spatial memory and smell detection!
A drug cocktail to increase lifespan in worms
A potassium channel may play a role in alcoholism!
Single cell RNA sequencing identifies distinct macrophage populations found in the liver!
The composition of gut bacteria almost recovers after antibiotics
Protocols
Dual-Angle Protocol for Doppler Optical Coherence Tomography to Improve Retinal Blood Flow Measur…
Detection of protein SUMOylation in vivo
In vivo analysis of protein sumoylation induced by a viral protein: Detection of HCMV pp71-induce…
Determination of SUMOylation sites
miR-Selection 3'UTR Target Selection Kit
Publications
Sequential Activation of Guide RNAs to Enable Successive CRISPR-Cas9 Activities
Differential DNA methylation in recovery from shift work disorder
Chromosomally unstable tumor cells specifically require KIF18A for proliferation
Data-Driven Modeling of Pregnancy- Related Complications
Seasonal Variation in the Brain l-Opioid Receptor Availability
Presentations
Mitochondrial Disorders
Blood Brain Barrier
Chromatin Structure
Age-Related Macular Degeneration
Cancer Epigenetics
Posters
ASCO-2020-CENTRAL NERVOUS SYSTEM TUMORS
ASCO-2020-DEVELOPMENTAL THERAPEUTICS–IMMUNOTHERAPY
ASCO-2020-DEVELOPMENTAL THERAPEUTICS–MOLECULARLY TARGETED AGENTS AND TUMOR BIOLOGY
ASCO-2020-CANCER PREVENTION, RISK REDUCTION, AND GENETICS
ASCO-2020-BREAST CANCER–METASTATIC